Form 4 for NEO NEOGENOMICS INC
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001077183-22-000148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-17 | 2022-08-15 | NEO | Smith Christopher M | CEO | A - Grant | $0.00 | +602.2K | 336.8K | New | $0 |
| D | 2022-08-17 | 2022-08-15 | NEO | Smith Christopher M | CEO | A - Grant | $0.00 | +694.4K | 694.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-15 | A | A | 265,452 | $0.00 | 602,219 | D | — | — | (F2) On August 15, 2022, Mr. Smith was granted 265,452 restricted stock awards. These awards vest on the fourth anniversary date of the grant date. |
| 2 | Common | Common Stock | 2022-08-15 | A | A | 336,767 | $0.00 | 336,767 | D | — | — | (F1) On August 15, 2022, Mr. Smith was granted 336,767 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-08-15 | A | A | 694,444 | $0.00 | 694,444 | D | $12.62 · — to 2029-08-15 | 694,444 Common Stock | (F3) On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date. |